The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy

被引:226
作者
Ha Thi Nguyen [1 ]
Hong-Quan Duong [2 ]
机构
[1] Duy Tan Univ, Inst Res & Dev, Ctr Mol Biol, 03 Quang Trung, Danang 550000, Vietnam
[2] Vinmec Res Inst Stem Cell & Gene Technol, Dept Canc Res, 458 Minh Khai, Hanoi 100000, Vietnam
关键词
colorectal cancer; chromosomal instability; microsatellite instability; CpG island methylator phenotype; molecular characteristics; early diagnosis; targeted therapy; ISLAND METHYLATOR PHENOTYPE; DEFECTIVE MISMATCH REPAIR; POPULATION-BASED SAMPLE; PLURIPOTENT STEM-CELLS; MICROSATELLITE-INSTABILITY; COLON-CANCER; TUMOR-SUPPRESSOR; KRAS MUTATIONS; K-RAS; CHROMOSOMAL INSTABILITY;
D O I
10.3892/ol.2018.8679
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Colorectal cancer (CRC) results from the progressive accumulation of multiple genetic and epigenetic aberrations within cells. The progression from colorectal adenoma to carcinoma is caused by three major pathways: Microsatellite instability, chromosomal instability and CpG island methylator phenotype. A growing body of scientific evidences suggests that CRC is a heterogeneous disease, and genetic characteristics of the tumors determine their prognostic outcome and response to targeted therapies. Early diagnosis and effective targeted therapies based on a current knowledge of the molecular characteristics of CRC are essential to the successful treatment of CRC. Therefore, the present review summarized the current understanding of the molecular characteristics of CRC, and discussed its implications for diagnosis and targeted therapy.
引用
收藏
页码:9 / 18
页数:10
相关论文
共 140 条
[1]
CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].
AALTONEN, LA ;
PELTOMAKI, P ;
LEACH, FS ;
SISTONEN, P ;
PYLKKANEN, L ;
MECKLIN, JP ;
JARVINEN, H ;
POWELL, SM ;
JEN, J ;
HAMILTON, SR ;
PETERSEN, GM ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A .
SCIENCE, 1993, 260 (5109) :812-816
[2]
Molecular basis and diagnostics of hereditary colorectal cancers [J].
Abdel-Rahman, WM ;
Peltomäki, N .
ANNALS OF MEDICINE, 2004, 36 (05) :379-388
[3]
Ras signaling pathway proteins as therapeutic targets [J].
Adjei, AA .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (16) :1581-1594
[4]
Molecular pathways in colorectal cancer [J].
Al-Sohaily, Sam ;
Biankin, Andrew ;
Leong, Rupert ;
Kohonen-Corish, Maija ;
Warusavitarne, Janindra .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) :1423-1431
[5]
SMAD4 as a prognostic marker in colorectal cancer [J].
Alazzouzi, H ;
Alhopuro, P ;
Salovaara, R ;
Sammalkorpi, H ;
Järvinen, H ;
Mecklin, JP ;
Hemminki, A ;
Schwartz, S ;
Aaltonen, LA ;
Arango, D .
CLINICAL CANCER RESEARCH, 2005, 11 (07) :2606-2611
[6]
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[7]
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage [J].
Amps, Katherine ;
Andrews, Peter W. ;
Anyfantis, George ;
Armstrong, Lyle ;
Avery, Stuart ;
Baharvand, Hossein ;
Baker, Julie ;
Baker, Duncan ;
Munoz, Maria B. ;
Beil, Stephen ;
Benvenisty, Nissim ;
Ben-Yosef, Dalit ;
Biancotti, Juan-Carlos ;
Bosman, Alexis ;
Brena, Romulo Martin ;
Brison, Daniel ;
Caisander, Gunilla ;
Camarasa, Maria V. ;
Chen, Jieming ;
Chiao, Eric ;
Choi, Young Min ;
Choo, Andre B. H. ;
Collins, Daniel ;
Colman, Alan ;
Crook, Jeremy M. ;
Daley, George Q. ;
Dalton, Anne ;
De Sousa, Paul A. ;
Denning, Chris ;
Downie, Janet ;
Dvorak, Petr ;
Montgomery, Karen D. ;
Feki, Anis ;
Ford, Angela ;
Fox, Victoria ;
Fraga, Ana M. ;
Frumkin, Tzvia ;
Ge, Lin ;
Gokhale, Paul J. ;
Golan-Lev, Tamar ;
Gourabi, Hamid ;
Gropp, Michal ;
Lu Guangxiu ;
Hampl, Ales ;
Harron, Katie ;
Healy, Lyn ;
Herath, Wishva ;
Holm, Frida ;
Hovatta, Outi ;
Hyllner, Johan .
NATURE BIOTECHNOLOGY, 2011, 29 (12) :1132-U113
[8]
[Anonymous], 2008, GASTROINTEST ENDOSC, DOI DOI 10.1016/J.GIEC.2008.03.003
[9]
[Anonymous], 2008, J APPL RES CLIN EXP
[10]
BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures [J].
Avery, Stuart ;
Hirst, Adam J. ;
Baker, Duncan ;
Lim, Chin Yan ;
Alagaratnam, Sharmini ;
Skotheim, Rolf I. ;
Lothe, Ragnhild A. ;
Pera, Martin F. ;
Colman, Alan ;
Robson, Paul ;
Andrews, Peter W. ;
Knowles, Barbara B. .
STEM CELL REPORTS, 2013, 1 (05) :379-386